أنتيروب كبسولات كليندامايسين لعلاج العدوى البكتيرية في الكلاب والقطط
Antirobe (clindamycin hydrochloride) is an oral lincosamide antibiotic capsule with outstanding tissue and bone penetration. Indicated in dogs and cats for the treatment of dental infections, osteomyelitis, deep soft tissue wounds, abscesses, and superficial/deep pyoderma caused by susceptible strains of Staphylococcus, Streptococcus, and anaerobic bacteria.
الشكل الصيدلاني
Capsule
نوع المنتج
دواء
الشركة المصنعة
الحجم
Bottles of 100 capsules (25 mg, 75 mg, 150 mg, and 300 mg clindamycin base)
| النوع الحيواني | الجرعة | طريقة الإعطاء | المدة |
|---|---|---|---|
| Dog | 5.5 to 11 mg/kg (2.5 to 5.0 mg/lb) body weight orally every 12 hours for soft tissue and dental infections; 11 mg/kg every 12 hours for osteomyelitis | Oral capsule | Administer for 7 to 28 consecutive days; continue for at least 48 hours after signs resolve |
| Cat | 11 to 22 mg/kg (5.0 to 10.0 mg/lb) body weight orally every 24 hours | Oral capsule | Administer for 7 to 14 days |
لا توجد معلومات سحب متاحة.
Treatment of periodontal infections and dental disease in dogs caused by susceptible anaerobes.
Treatment of osteomyelitis caused by Staphylococcus aureus in dogs.
Treatment of wounds, abscesses, and pyoderma in dogs and cats caused by susceptible Gram-positive and anaerobic pathogens.
Do not use in animals known to be hypersensitive to clindamycin or lincomycin.
Not for use in rabbits, guinea pigs, chinchillas, or horses.
Use with caution in animals with severe renal or hepatic disease.
Vomiting, loose stools, or transient anorexia.
Antirobe (clindamycin hydrochloride) Prescribing Information
نشرة150 mg/capsule (as hydrochloride)
لا توجد أمراض مرتبطة.
لا توجد بيانات
لم تتم إضافة المعلومات بعد.
شركة مصنعة
لا توجد بدائل متاحة.